Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Allergan USA, Inc. v. Prescribers Choice, Inc et al
Case Number:
8:17-cv-01550
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
February 01, 2019
Allergan Deal Gets Compounder To Say Drugs Not FDA-OK'd
Allergan Inc.'s aggressive bid to block sales of lower-cost compounded drugs has ended with a compounder's agreement to tell customers that its products aren't approved by the U.S. Food and Drug Administration.
-
January 14, 2019
Allergan's Attack On Drug Compounding Falls Flat
A California federal judge has rejected Allergan Inc.'s high-stakes effort to make many drug compounding activities unlawful, saying he will defer to the U.S. Food and Drug Administration's decision to allow the activities.
-
October 22, 2018
Allergan Fights For Ropes & Gray Docs In Compounder IP Suit
Allergan PLC has asked a California federal court to force drug compounders to hand over communications with Ropes & Gray LLP in its suit over alleged copycat drugs, saying the documents lost attorney-client privilege when the compounders sent a memo written by the firm to health care providers assuring them the businesses were legal.
-
July 17, 2018
Allergan Awarded $27K In Sanctions In Compounding Suit
Allergan USA Inc. has been awarded nearly $27,300 in sanctions, according to an order in California federal court on Monday, after accusing drug compounders in its suit over copycat drugs of improperly delaying and withholding discovery.
-
November 27, 2017
'Seminal' Allergan Cases Test Copycat Drug Limits
Two recently filed lawsuits from Allergan PLC are teeing up a pivotal test of the extent to which drug compounders can mass-produce virtual copies of brand-name prescription drugs, attorneys say.